AZITHROMYCIN
AZITHROMYCIN- azithromycin monohydrate powder, for suspension
PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
1 INDICATIONS AND USAGE
Azithromycin for oral suspension USP is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications. [see Dosage and Administration (2)]
2 DOSAGE AND ADMINISTRATION
2.1 Adult Patients
[see Indications and Usage (1.1) and Clinical Pharmacology (12.3)]
Infection* | Recommended Dose/Duration of Therapy |
Community-acquired pneumonia Pharyngitis/tonsillitis (second-line therapy) Skin/skin structure (uncomplicated) | 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5 |
Acute bacterial exacerbations of chronic obstructive pulmonary disease | 500 mg once daily for 3 days OR 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5 |
Acute bacterial sinusitis | 500 mg-once daily for 3 days |
Genital ulcer disease (chancroid) | One single 1 gram dose |
Non-gonococcal urethritis and cervicitis | One single 1 gram dose |
Gonococcal urethritis and cervicitis | One single 2 gram dose |
*DUE TO THE INDICATED ORGANISMS [see Indications and Usage (1.1)] |
Azithromycin tablets can be taken with or without food.
2.2 Pediatric Patients1
Infection* | Recommended Dose/Duration of Therapy |
Acute otitis media | 30 mg/kg as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on Day 1 followed by 5 mg/kg/day on Days 2 through 5. |
Acute bacterial sinusitis | 10 mg/kg once daily for 3 days. |
Community-acquired pneumonia | 10 mg/kg as a single dose on Day 1 followed by 5 mg/kg once daily on Days 2 through 5. |
Pharyngitis/tonsillitis | 12 mg/kg once daily for 5 days. |
*DUE TO THE INDICATED ORGANISMS [see Indications and Usage (1.2)] 1 see dosing tables below for maximum doses evaluated by indication |
Azithromycin for oral suspension can be taken with or without food.
PEDIATRIC DOSAGE GUIDELINES FOR OTITIS MEDIA, ACUTE BACTERIAL SINUSITIS, AND COMMUNITY-ACQUIRED PNEUMONIA (Age 6 months and above, [see Use in Specific Populations (8.4)]) Based on Body Weight | ||||||
OTITIS MEDIA AND COMMUNITY-ACQUIRED PNEUMONIA: (5-Day Regimen)* | ||||||
Dosing Calculated on 10 mg/kg/day Day 1 and 5 mg/kg/day Days 2 to 5. | ||||||
Weight | 100 mg/5 mL | 200 mg/5 mL | Total mL per Treatment Course | Total mg per Treatment Course | ||
Kg | Day 1 | Days 2-5 | Day 1 | Days 2-5 | ||
5 | 2.5 mL; (½ tsp) | 1.25 mL; (¼ tsp) | 7.5 mL | 150 mg | ||
10 | 5 mL; (1 tsp) | 2.5 mL; (½ tsp) | 15 mL | 300 mg | ||
20 | 5 mL; (1 tsp) | 2.5 mL; (½ tsp) | 15 mL | 600 mg | ||
30 | 7.5 mL; (1½ tsp) | 3.75 mL; (¾ tsp) | 22.5 mL | 900 mg | ||
40 | 10 mL; (2 tsp) | 5 mL; (1 tsp) | 30 mL | 1200 mg | ||
50 and above | 12.5 mL; (2½ tsp) | 6.25 mL; (1¼ tsp) | 37.5 mL | 1500 mg |
*Effectiveness of the 3-day or 1-day regimen in pediatric patients with community-acquired pneumonia has not been established.
OTITIS MEDIA AND ACUTE BACTERIAL SINUSITIS: (3-Day Regimen)* | ||||
Dosing Calculated on 10 mg/kg/day. | ||||
Weight | 100 mg/5 mL | 200 mg/5 mL | Total mL per Treatment Course | Total mg per Treatment Course |
Kg | Days 1-3 | Days 1-3 | ||
5 | 2.5 mL; (½ tsp) | 7.5 mL | 150 mg | |
10 | 5 mL; (1 tsp) | 15 mL | 300 mg | |
20 | 5 mL (1 tsp) | 15 mL | 600 mg | |
30 | 7.5 mL (1½ tsp) | 22.5 mL | 900 mg | |
40 | 10 mL (2 tsp) | 30 mL | 1200 mg | |
50 and above | 12.5 mL (2½ tsp) | 37.5 mL | 1500 mg |
*Effectiveness of the 5-day or 1-day regimen in pediatric patients with acute bacterial sinusitis has not been established.
OTITIS MEDIA: (1-Day Regimen) | |||
Dosing Calculated on 30mg/kg as a single dose. | |||
Weight | 200 mg/5 mL | Total mL per Treatment Course | Total mg per Treatment Course |
Kg | 1-Day Regimen | ||
5 | 3.75 mL; (¾ tsp) | 3.75 mL | 150 mg |
10 | 7.5 mL; (1½ tsp) | 7.5 mL | 300 mg |
20 | 15 mL; (3 tsp) | 15 mL | 600 mg |
30 | 22.5 mL; ( 4½ tsp) | 22.5 mL | 900 mg |
40 | 30 mL;(6 tsp) | 30 mL | 1200 mg |
50 and above | 37.5 mL; (7½ tsp) | 37.5 mL | 1500 mg |
The safety of re-dosing azithromycin in pediatric patients who vomit after receiving 30 mg/kg as a single dose has not been established. In clinical studies involving 487 patients with acute otitis media given a single 30 mg/kg dose of azithromycin, 8 patients who vomited within 30 minutes of dosing were re-dosed at the same total dose.
Pharyngitis/Tonsillitis: The recommended dose of azithromycin for children with pharyngitis/tonsillitis is 12 mg/kg once daily for 5 days. (See chart below.)
PEDIATRIC DOSAGE GUIDELINES FOR PHARYNGITIS/TONSILLITIS (Age 2 years and above, [see Use in Specific Populations (8.4)]) Based on Body Weight | |||
PHARYNGITIS/TONSILLITIS: (5-Day Regimen) | |||
Dosing Calculated on 12 mg/kg/day for 5 days. | |||
Weight | 200 mg/5 mL | Total mL per Treatment Course | Total mg per Treatment Course |
Kg | Day 1-5 | ||
8 | 2.5 mL; (½ tsp) | 12.5 mL | 500 mg |
17 | 5 mL; (1 tsp) | 25 mL | 1000 mg |
25 | 7.5 mL; (1½ tsp) | 37.5 mL | 1500 mg |
33 | 10 mL; (2 tsp) | 50 mL | 2000 mg |
40 | 12.5 mL; (2½ tsp) | 62.5 mL | 2500 mg |
Constituting instructions for Azithromycin Oral Suspension 300, 600, 900, 1200 mg bottles. The table below indicates the volume of water to be used for constitution:
Amount of water to be added | Total volume after constitution (azithromycin content) | Azithromycin concentration after constitution |
9 mL (300 mg) | 15 mL (300 mg) | 100 mg/5 mL |
9 mL (600 mg) | 15 mL (600 mg) | 200 mg/5 mL |
12 mL (900 mg) | 22.5 mL (900 mg) | 200 mg/5 mL |
15 mL (1200 mg) | 30 mL (1200 mg) | 200 mg/5 mL |
Shake well before each use. Oversized bottle provides shake space. Keep tightly closed.
After mixing, store suspension at 5° to 30°C (41° to 86°F) and use within 10 days. Discard after full dosing is completed.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.